BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/20/2024 3:42:22 AM | Browse: 72 | Download: 157
 |
Received |
|
2024-02-17 08:40 |
|
Peer-Review Started |
|
2024-02-17 08:40 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-04-13 16:45 |
|
Revised |
|
2024-04-23 08:20 |
|
Second Decision |
|
2024-04-29 03:03 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-04-29 06:59 |
|
Articles in Press |
|
2024-04-29 06:59 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-05-31 09:05 |
|
Publish the Manuscript Online |
|
2024-06-20 03:42 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Editorial |
| Article Title |
Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rochelle Wong and Li-Yun Yuan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Rochelle Wong, MD, Doctor, Doctor, Division of Gastrointestinal and Liver Diseases, Keck School of Medicine of University of Southern California, 1510 San Pablo St. HC1 - Suite 200, Los Angeles, CA 90033, United States. rochellewong15@gmail.com |
| Key Words |
Sarcopenia; Steatotic liver disease; Metabolic dysfunction; Insulin resistance; Liver-muscle axis |
| Core Tip |
Sarcopenia and metabolic dysfunction associated steatotic liver disease (MASLD) share a bidirectional relationship along the liver-muscle axis. With similar pathophysiology and shared risk factors, MASLD is a risk factor for sarcopenia, and vice versa. Early identification and adequate diagnosis are important. However, lack of consensus definition made it difficult to research outcomes. With the recently updated consensus definition for MASLD, researchers may now better identify proper cohorts for study. Consensus on gold standard techniques and muscle mass cutoffs to define sarcopenia are still needed. Future research may identify potential therapeutic targets along the shared liver-muscle axis that would improve outcomes for both sarcopenia and MASLD. |
| Publish Date |
2024-06-20 03:42 |
| Citation |
<p>Wong R, Yuan LY. Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both. <i>World J Hepatol</i> 2024; 16(6): 871-877</p> |
| URL |
https://www.wjgnet.com/1948-5182/full/v16/i6/871.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v16.i6.871 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
